In this study, we demonstrated that WBRT plus SIB had promising effect on intra-cranial tumor control and could improve patient survival in breast cancer with brain metastasis, especially in patients with HER2-postive tumors. This evidence concerns the gene ERBB2 and breast carcinoma.